Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650784PMC
http://dx.doi.org/10.1164/rccm.202103-0612EDDOI Listing

Publication Analysis

Top Keywords

phase-2 nih-sponsored
4
nih-sponsored randomized
4
randomized clinical
4
clinical trial
4
trial rituximab
4
rituximab scleroderma-associated
4
scleroderma-associated pulmonary
4
pulmonary arterial
4
arterial hypertension
4
hypertension reach
4

Similar Publications

The origins of theories specifying dietary restraint as a cause of eating disorders can be traced to the 1970s. This paper will present an overview of the origins of dietary restraint theories and a brief historical review of evidence will be summarized. Recent research will be presented, including the results from the CALERIE Phase 1 study, as well as CALERIE Phase 2, which were NIH-sponsored randomized controlled trials.

View Article and Find Full Text PDF

Importance: Preclinical studies suggest that inhibition of single-stranded DNA repair by ataxia telangiectasia and Rad3 (ATR) may enhance the cytotoxicity of cisplatin, gemcitabine, and other chemotherapeutic agents. Cisplatin with gemcitabine remains the standard up-front therapy for treatment in patients with metastatic urothelial cancer.

Objective: To determine whether the use of the selective ATR inhibitor, berzosertib, could augment the activity of cisplatin with gemcitabine.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!